A Clinical Trial Evaluating the Efficacy of a Skin Cream in Improving Facial Appearance and Skin Elasticity
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04769193 |
|
Recruitment Status :
Recruiting
First Posted : February 24, 2021
Last Update Posted : March 2, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Atrophy, Hemifacial Elastosis Photoaging | Other: Adipeau face cream | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 75 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Masking Description: | The evaluation of skin volume will be masked as the assessors will not known which scans are from what time period. |
| Primary Purpose: | Treatment |
| Official Title: | A Clinical Trial Evaluating the Efficacy of a Skin Cream Targeting Dermal Fat in Improving the Skin Elasticity of Healthy Volunteers |
| Actual Study Start Date : | January 27, 2021 |
| Estimated Primary Completion Date : | March 27, 2022 |
| Estimated Study Completion Date : | June 27, 2022 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Adipeau face cream
Cosmetic cream
|
Other: Adipeau face cream
Adipeau face cream contains the natural actives Carthamus Tinctorius (Safflower) Seed Oil and Kaempferia Parviflora Rhizome Extract (Black Ginger). |
- Change in Skin Elasticity [ Time Frame: Six months and 12 months.. ]Elasticity measured by DermaLab Skin Elasticity Meter.
- Change in Skin Volume [ Time Frame: Six months and 12 Months. ]Increases and decreases measured by Cherry Imaging 3D Scanning System.
- FaceQ skin satisfaction surveys [ Time Frame: Two, Six and 12 Months. ]Satisfaction With Skin, Appraisal of Lower Eyelids, Satisfaction with Cheeks, Adverse Effects
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 75 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
-
Exclusion Criteria:
- Plans to undergo facial skin resurfacing (e.g. laser, chemical peel, microneedling) during the study period
- Plans to undergo injectable filler treatment.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04769193
| Contact: Jacob Tower, MD | 646-694-0991 | care@adipeau.com |
| United States, New York | |
| Thomas Romo Plastic Surgery | Recruiting |
| New York, New York, United States, 10021 | |
| Contact: Thomas Romo, MD 212-288-1500 dr.romo@romoplasticsurgery.com | |
| Principal Investigator: | Jacob Tower, MD | Romo Plastic Surgery |
| Responsible Party: | Adipeau Inc. |
| ClinicalTrials.gov Identifier: | NCT04769193 |
| Other Study ID Numbers: |
Adipeau-001 |
| First Posted: | February 24, 2021 Key Record Dates |
| Last Update Posted: | March 2, 2021 |
| Last Verified: | February 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Sagging Depletion Atrophy Photoaging |
|
Facial Hemiatrophy Atrophy Pathological Conditions, Anatomical Mouth Diseases |
Stomatognathic Diseases Facial Nerve Diseases Cranial Nerve Diseases Nervous System Diseases |

